These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6473150)

  • 1. Synthesis, conformational studies and biological activities of VIP and related fragments.
    Fournier A; Saunders JK; St-Pierre S
    Peptides; 1984; 5(2):169-77. PubMed ID: 6473150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of vasoactive intestinal peptide (VIP) via the mixed anhydride method.
    Schaaper WM; Beyerman HC
    Peptides; 1984; 5(2):167-8. PubMed ID: 6473149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of vasoactive intestinal polypeptide (11-28)-NH2, a fragment with analgesic properties.
    Haghjoo K; Cash PW; Farid RS; Komisaruk BR; Jordan F; Pochapsky SS
    Pept Res; 1996; 9(6):327-31. PubMed ID: 9048428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-phase synthesis of porcine vasoactive intestinal peptide.
    Coy DH; Gardner J
    Int J Pept Protein Res; 1980 Jan; 15(1):73-8. PubMed ID: 7358460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined solid-phase/solution synthesis of a 31-residue vasoactive intestinal peptide analog: general method for repetitive coupling of fragments without isolation and purification of intermediates.
    Felix AM; Zhao Z; Lambros T; Ahmad M; Liu W; Daniewski A; Michalewsky J; Heimer EP
    J Pept Res; 1998 Aug; 52(2):155-64. PubMed ID: 9727872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological properties of the N-terminal decapeptide of the vasoactive intestinal peptide (VIP).
    Bodanszky M; Henes JB; Yiotakis AE; Said SI
    J Med Chem; 1977 Nov; 20(11):1461-4. PubMed ID: 915906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
    Goossens JF; Pommery N; Lohez M; Pommery J; Helbecque N; Cotelle P; Lhermitte M; Henichart JP
    Mol Pharmacol; 1992 Jan; 41(1):104-9. PubMed ID: 1732717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformation of a peptide corresponding to T4 lysozyme residues 59-81 by NMR and CD spectroscopy.
    McLeish MJ; Nielsen KJ; Najbar LV; Wade JD; Lin F; Doughty MB; Craik DJ
    Biochemistry; 1994 Sep; 33(37):11174-83. PubMed ID: 7727368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of helix-based vasoactive intestinal peptide analogues: identification of residues required for receptor interaction.
    Musso GF; Patthi S; Ryskamp TC; Provow S; Kaiser ET; Veliçelebi G
    Biochemistry; 1988 Oct; 27(21):8174-81. PubMed ID: 2852954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of VIP on guinea pig taenia coli requires the whole sequence.
    Pipkorn R; Håkanson R
    Peptides; 1984; 5(2):267-9. PubMed ID: 6473155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and photolytic cleavage of bovine insulin B22-30 on a nitrobenzoylglycyl-poly (ethylene glycol) support.
    Stüber W; Hemmasi B; Bayer E
    Int J Pept Protein Res; 1983 Sep; 22(3):277-83. PubMed ID: 6354952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors.
    Gourlet P; Rathé J; De Neef P; Cnudde J; Vandermeers-Piret MC; Waelbroeck M; Robberecht P
    Eur J Pharmacol; 1998 Jul; 354(1):105-11. PubMed ID: 9726637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
    Gourlet P; Vandermeers A; Van Rampelbergh J; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
    Ann N Y Acad Sci; 1998 Dec; 865():247-52. PubMed ID: 9928018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro properties of a high affinity selective antagonist of the VIP1 receptor.
    Gourlet P; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
    Peptides; 1997; 18(10):1555-60. PubMed ID: 9437716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-helical structure in the C-terminus of vasoactive intestinal peptide: functional and structural consequences.
    Onoue S; Matsumoto A; Nagano Y; Ohshima K; Ohmori Y; Yamada S; Kimura R; Yajima T; Kashimoto K
    Eur J Pharmacol; 2004 Feb; 485(1-3):307-16. PubMed ID: 14757155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase synthesis of chicken vasoactive intestinal peptide by a mild procedure using N alpha-9-fluorenylmethyloxycarbonyl amino acids.
    Colombo R
    Int J Pept Protein Res; 1982 Jan; 19(1):71-8. PubMed ID: 7118383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor.
    Moreno D; Gourlet P; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
    Peptides; 2000 Oct; 21(10):1543-9. PubMed ID: 11068102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure of an analogue of vasoactive intestinal peptide as determined by two-dimensional NMR and circular dichroism spectroscopies and constrained molecular dynamics.
    Fry DC; Madison VS; Bolin DR; Greeley DN; Toome V; Wegrzynski BB
    Biochemistry; 1989 Mar; 28(6):2399-409. PubMed ID: 2730873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the synthesis and purification of transmembrane peptide fragments. Rat bradykinin receptor fragment 64-97 as model.
    Oliveira E; Miranda A; Albericio F; Andreu D; Paiva AC; Nakaie CR; Tominaga M
    J Pept Res; 1997 Apr; 49(4):300-7. PubMed ID: 9176813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragments of the second transmembrane helix of three G-protein-coupled receptors: comparative synthetic, structural and conformational studies.
    Lopes DD; Cuvero JH; Ferreira MML; Silva RL; Souza SEG; Malavolta L; Schreier S; Nakaie CR
    Amino Acids; 2019 Feb; 51(2):273-282. PubMed ID: 30298243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.